Listed

InspireMD, Inc.

NSPRNasdaqCIK 1433607HealthcareFiscal year ends Dec 31

Reports and events: 529 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

InspireMD, Inc., Reports and events
FiledFormWhat it isAccession number
2024-08-0516:30 ET10-QQuarterly reportPeriod 2024-06-300001493152-24-030265
2024-07-0107:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-025714
2024-06-1316:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-023685
2024-06-1208:10 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-24-023546
2024-05-3116:52 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-022222
2024-05-2809:05 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-021463
2024-05-1407:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-019080
2024-05-1316:15 ET10-QQuarterly reportPeriod 2024-03-310001493152-24-018889
2024-04-1816:15 ETDEF 14AProxy statementPeriod 2024-04-180001493152-24-015191
2024-04-0209:14 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-24-012648
2024-03-2607:56 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-011233
2024-03-0607:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-008941
2024-03-0516:05 ET10-KAnnual reportPeriod 2023-12-310001493152-24-008850
2024-01-3108:09 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-004411
2023-12-2007:22 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-045512
2023-11-2707:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-042709
2023-11-0616:05 ET10-QQuarterly reportPeriod 2023-09-300001493152-23-039519
2023-11-0607:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-039434
2023-11-0114:31 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-038979
2023-10-1208:24 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-036981
2023-10-0616:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-23-036502
2023-09-1316:15 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-23-032486
2023-08-3108:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-030726
2023-08-0807:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-027101
2023-08-0717:25 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-027060
2023-07-2816:30 ETDEF 14AProxy statementPeriod 2023-07-280001493152-23-025891
2023-07-2116:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-23-025237
2023-06-2608:25 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-022352
2023-06-1616:15 ETSC 13DOwnership report, active investor0001493152-23-021668
2023-05-2309:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-018659
2023-05-1609:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-017646
2023-05-1516:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-017367
2023-05-1516:06 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-017317
2023-03-3008:02 ET10-KAnnual reportPeriod 2022-12-310001493152-23-009598
2023-03-3007:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-009596
2023-03-2008:10 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-008192
2022-11-0807:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-030876
2022-11-0716:05 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-030818
2022-09-0116:15 ET8-K5.07 Shareholder vote results0001493152-22-024842
2022-08-1116:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-022086
2022-08-0816:06 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-021613
2022-07-0516:30 ETDEF 14AProxy statementPeriod 2022-07-050001493152-22-018544
2022-06-0317:02 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-015872
2022-05-2016:15 ET8-K8.01 Other events0001493152-22-014604
2022-05-1007:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-012618
2022-05-0916:30 ET10-QQuarterly reportPeriod 2022-03-310001493152-22-012567
2022-03-0809:27 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-006266
2022-03-0716:25 ET10-KAnnual reportPeriod 2021-12-310001493152-22-006180
2022-02-2809:22 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-005566
2022-01-1016:43 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-000829

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:46 ET. Listed shows no prices and gives no investment advice.